The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials
Preclinical studies have demonstrated that statins have anticancer properties and act in an additive or synergistic way when combined with anticancer therapy. We conducted this meta-analysis of randomized, controlled phase II or III trials to evaluate the effect of statins added to systemic anticanc...
Main Authors: | Hyun Joo Jang, Hyeong Su Kim, Jung Han Kim, Jin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/7/10/325 |
Similar Items
-
Statins & risk of Clostridium difficile infection: A meta-analysis
by: Karn Wijarnpreecha, et al.
Published: (2019-01-01) -
Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
by: Nijole Bernaitis, et al.
Published: (2018-05-01) -
Potential drug interactions with statins:
Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01) -
Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study
by: Abraham Simatupang, et al.
Published: (2018-10-01) -
The Application of Statins in the Regeneration of Bone Defects. Systematic Review and Meta-Analysis
by: Elisabet Roca-Millan, et al.
Published: (2019-09-01)